Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis.
about
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis.
@en
type
label
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis.
@en
prefLabel
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis.
@en
P2860
P356
P1476
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis.
@en
P2093
Elliot M Frohman
J Theodore Phillips
P2860
P304
P356
10.1177/1756285608099124
P577
2008-11-01T00:00:00Z